News Industry News Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers September 15, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016
News Daily News Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis Caitlin E. Cox October 23, 2013
News Daily News After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin July 24, 2013
News Daily News Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients L.A. McKeown October 10, 2012